EquityZen Growth Technology Fund LLC - Series 2265
Raised
$364K
Investors
24
Min Invest
$10,074
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2265 is a Delaware SPV filed by EquityZen Advisors LLC that raised $364K from 24 investors under Rule 506(b) and Section 3(c)(1). The offering has a $10K minimum investment and is part of EquityZen's platform of over 1,800 pre-IPO investment vehicles, providing access to private technology company shares.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pattern common to EquityZen's syndicate platform, enabling accredited investors to participate in secondary market shares of private companies. The $10K minimum is typical for retail-accessible pre-IPO pooled vehicles, well below the $100K+ thresholds seen in institutional secondary funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
